Search

everythinglearnresearchcommunity

for

Search:↓

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

People with Behçet's disease can develop life-threatening lung artery aneurysms that may require surgery.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Baricitinib successfully treated severe hair loss.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Targeting NETs may help reduce fibrosis in Crohn's disease.